Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Shanghai Shyndec Pharmaceutical Co Ltd cash flow reinvestment rate. Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥67.11 Million (capex CN¥67.11 Million ) from operating cash flow of CN¥486.04 Million. Explore how well can Shanghai Shyndec Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Cash flow reinvestment rate of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. Historical reinvestment intensity for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Explore Shanghai Shyndec Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2004–2025)
Shanghai Shyndec Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2004 to 2025. Year-by-year capital reinvestment analysis for Shanghai Shyndec Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600420 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥305.40 Million | CN¥1.70 Billion | CN¥263.83 Million | ▲ +69.1% |
| 2024 | 0.11x | CN¥239.87 Million | CN¥2.26 Billion | CN¥219.77 Million | ▼ -83.9% |
| 2023 | 0.66x | CN¥1.14 Billion | CN¥1.72 Billion | CN¥357.19 Million | ▲ +209.3% |
| 2022 | 0.21x | CN¥609.88 Million | CN¥2.86 Billion | CN¥307.44 Million | ▼ -31.4% |
| 2021 | 0.31x | CN¥522.58 Million | CN¥1.68 Billion | CN¥521.44 Million | ▼ -17.1% |
| 2020 | 0.38x | CN¥585.79 Million | CN¥1.56 Billion | CN¥377.98 Million | ▲ +16.8% |
| 2019 | 0.32x | CN¥408.42 Million | CN¥1.27 Billion | CN¥403.82 Million | ▼ -30.6% |
| 2018 | 0.46x | CN¥772.95 Million | CN¥1.67 Billion | CN¥399.40 Million | ▲ +523.4% |
| 2017 | 0.07x | CN¥171.94 Million | CN¥2.31 Billion | CN¥168.44 Million | ▼ -79.6% |
| 2016 | 0.36x | CN¥305.85 Million | CN¥838.58 Million | CN¥241.30 Million | ▼ -69.6% |
| 2015 | 1.20x | CN¥271.86 Million | CN¥226.65 Million | CN¥234.52 Million | ▼ -28.0% |
| 2014 | 1.67x | CN¥430.53 Million | CN¥258.51 Million | CN¥430.53 Million | ▼ -32.6% |
| 2013 | 2.47x | CN¥512.62 Million | CN¥207.50 Million | CN¥512.62 Million | ▲ +17.8% |
| 2012 | 2.10x | CN¥405.52 Million | CN¥193.41 Million | CN¥405.52 Million | ▲ +122.3% |
| 2011 | 0.94x | CN¥128.40 Million | CN¥136.12 Million | CN¥128.40 Million | ▼ -30.4% |
| 2010 | 1.36x | CN¥156.02 Million | CN¥115.11 Million | CN¥156.02 Million | ▲ +322.0% |
| 2009 | 0.32x | CN¥31.29 Million | CN¥97.43 Million | CN¥31.29 Million | ▲ +37.5% |
| 2008 | 0.23x | CN¥13.56 Million | CN¥58.04 Million | CN¥13.56 Million | ▼ -44.2% |
| 2007 | 0.42x | CN¥34.45 Million | CN¥82.31 Million | CN¥34.45 Million | ▼ -50.3% |
| 2006 | 0.84x | CN¥62.00 Million | CN¥73.60 Million | CN¥62.00 Million | ▼ -31.9% |
| 2005 | 1.24x | CN¥71.65 Million | CN¥57.90 Million | CN¥71.65 Million | ▲ +33.4% |
| 2004 | 0.93x | CN¥15.79 Million | CN¥17.02 Million | CN¥15.79 Million | — |